Abstract |
Henoch-Schonlein purpura, also called IgA-vasculitis, is a systemic small vessels vasculitis with immunoglobulin A1-dominant immune deposits. The optimal treatment remains controversial. Because IgA-vasculitis is characterized by leukocyte infiltration of the blood vessel walls along with immunoglobulin A deposition, and because glucocorticosteroids inhibit inflammatory processes, early administration of glucocorticosteroids has been postulated to be effective, but this indication remains controversial. Immunosuppressive agents ( azathioprine, cyclophosphamide, cyclosporine, mycophenolate) have been used in combination with glucocorticosteroids without definitive evidence of effectiveness. The efficacy of rituximab in adult IgA-vasculitis has been reported in few cases. We described a monocentric experience on the use of rituximab in adult IgA-vasculitis with biopsy-proven nephritis. The patients achieved a complete remission of nephritis and syndromic manifestations, and no patients experienced adverse reactions. These data have been compared with the limited literature nowadays available.
|
Authors | Roberta Fenoglio, Carla Naretto, Bruno Basolo, Giacomo Quattrocchio, Michela Ferro, Paola Mesiano, Giulietta Beltrame, Dario Roccatello |
Journal | Immunologic research
(Immunol Res)
Vol. 65
Issue 1
Pg. 186-192
(02 2017)
ISSN: 1559-0755 [Electronic] United States |
PMID | 27449502
(Publication Type: Case Reports, Journal Article, Review)
|
Chemical References |
- Immunosuppressive Agents
- Rituximab
|
Topics |
- Adult
- Aged
- Female
- Humans
- IgA Vasculitis
(drug therapy)
- Immunosuppressive Agents
(therapeutic use)
- Male
- Middle Aged
- Nephritis
(drug therapy)
- Rituximab
(therapeutic use)
- Young Adult
|